Intellia Therapeutics
NTLA
NTLA
284 hedge funds and large institutions have $2.53B invested in Intellia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 120 increasing their positions, 66 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
8% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 37
2% less funds holding
Funds holding: 290 → 284 (-6)
21% less capital invested
Capital invested by funds: $3.19B → $2.53B (-$656M)
Holders
284
Holding in Top 10
6
Calls
$13.4M
Puts
$12.8M
Top Buyers
| 1 | +$45.2M | |
| 2 | +$16.4M | |
| 3 | +$15.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.2M |
| 5 |
Morgan Stanley
New York
|
+$9.38M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$9.64M | |
| 3 | -$8.4M | |
| 4 |
Goldman Sachs
New York
|
-$8.05M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$7.55M |